Equities

Cryo-Cell International Inc

Cryo-Cell International Inc

Actions
Health CareHealth Care Providers
  • Price (USD)8.30
  • Today's Change0.43 / 5.46%
  • Shares traded15.51k
  • 1 Year change+91.69%
  • Beta0.4665
Data delayed at least 15 minutes, as of Nov 22 2024 01:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Nov 30 2023202320222021
ASSETS
Cash And Short Term Investments0.981.728.34
Total Receivables, Net6.586.045.25
Total Inventory0.770.850.92
Prepaid expenses0.620.570.56
Other current assets, total0.510.430.71
Total current assets9.459.6116
Property, plant & equipment, net22144.15
Goodwill, net1.941.941.94
Intangibles, net0.991.461.56
Long term investments0.310.310.31
Note receivable - long term------
Other long term assets6.012425
Total assets616561
LIABILITIES
Accounts payable3.171.611.49
Accrued expenses3.483.092.94
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.170.151.90
Other current liabilities, total141515
Total current liabilities211921
Total long term debt8.438.580
Total debt8.608.731.90
Deferred income tax------
Minority interest------
Other liabilities, total433835
Total liabilities726656
SHAREHOLDERS EQUITY
Common stock0.150.150.15
Additional paid-in capital434342
Retained earnings (accumulated deficit)(31)(22)(17)
Treasury stock - common(23)(23)(21)
Unrealized gain (loss)------
Other equity, total------
Total equity(11)(1.52)4.18
Total liabilities & shareholders' equity616561
Total common shares outstanding8.298.508.56
Treasury shares - common primary issue6.566.356.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.